Cargando…

Concordance in survival among first‐degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia

OBJECTIVES: To investigate concordance in survival time among first‐degree relatives with lymphoid malignancies. METHODS: By linkage of national Swedish registers, we identified 66 430 patients diagnosed with a lymphoid malignancy 1958‐2016 with information on first‐degree relationships and follow‐u...

Descripción completa

Detalles Bibliográficos
Autores principales: Baecklund, Fredrik, Ekberg, Sara, Rosenquist, Richard, Askling, Johan, Eloranta, Sandra, Smedby, Karin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702025/
https://www.ncbi.nlm.nih.gov/pubmed/32871627
http://dx.doi.org/10.1111/ejh.13510
_version_ 1783616528930832384
author Baecklund, Fredrik
Ekberg, Sara
Rosenquist, Richard
Askling, Johan
Eloranta, Sandra
Smedby, Karin E.
author_facet Baecklund, Fredrik
Ekberg, Sara
Rosenquist, Richard
Askling, Johan
Eloranta, Sandra
Smedby, Karin E.
author_sort Baecklund, Fredrik
collection PubMed
description OBJECTIVES: To investigate concordance in survival time among first‐degree relatives with lymphoid malignancies. METHODS: By linkage of national Swedish registers, we identified 66 430 patients diagnosed with a lymphoid malignancy 1958‐2016 with information on first‐degree relationships and follow‐up until 2017. Among these, we identified pairs of first‐degree relatives with any (N = 3326) or a similar (N = 690) lymphoid malignancy subtype. We defined survival in the first‐degree relative as good, expected, or poor based on tertiles of deviance residuals from a multivariable Cox regression model. Next, we used Cox regression to estimate hazard ratios (HR) of death with 95% confidence intervals (CI) among patients, using the survival of their first‐degree relative as exposure and adjusting for confounders. RESULTS: There was no concordance in survival among first‐degree relatives with any lymphoid malignancy (HR(good) = 1.00 (reference), HR(Expected) = 1.02, 95% CI: 0.89‐1.17, HR(Poor) = 1.12, 95% CI: 0.98‐1.27, P (trend) = .08). Among first‐degree relatives with indolent lymphoma, including chronic lymphocytic leukemia, those with a first‐degree relative to an expected or poor survival had worse outcome compared to those with a first‐degree relative with good survival (HR(Expected) = 1.44, 95% CI: 0.82‐2.53, HR(Poor) = 1.79, 95% CI: 1.07‐3.00, P (trend) = .03). CONCLUSION: Our results support a role of inherited factors in the outcome of indolent lymphoma, including chronic lymphocytic leukemia.
format Online
Article
Text
id pubmed-7702025
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77020252020-12-14 Concordance in survival among first‐degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia Baecklund, Fredrik Ekberg, Sara Rosenquist, Richard Askling, Johan Eloranta, Sandra Smedby, Karin E. Eur J Haematol Original Articles OBJECTIVES: To investigate concordance in survival time among first‐degree relatives with lymphoid malignancies. METHODS: By linkage of national Swedish registers, we identified 66 430 patients diagnosed with a lymphoid malignancy 1958‐2016 with information on first‐degree relationships and follow‐up until 2017. Among these, we identified pairs of first‐degree relatives with any (N = 3326) or a similar (N = 690) lymphoid malignancy subtype. We defined survival in the first‐degree relative as good, expected, or poor based on tertiles of deviance residuals from a multivariable Cox regression model. Next, we used Cox regression to estimate hazard ratios (HR) of death with 95% confidence intervals (CI) among patients, using the survival of their first‐degree relative as exposure and adjusting for confounders. RESULTS: There was no concordance in survival among first‐degree relatives with any lymphoid malignancy (HR(good) = 1.00 (reference), HR(Expected) = 1.02, 95% CI: 0.89‐1.17, HR(Poor) = 1.12, 95% CI: 0.98‐1.27, P (trend) = .08). Among first‐degree relatives with indolent lymphoma, including chronic lymphocytic leukemia, those with a first‐degree relative to an expected or poor survival had worse outcome compared to those with a first‐degree relative with good survival (HR(Expected) = 1.44, 95% CI: 0.82‐2.53, HR(Poor) = 1.79, 95% CI: 1.07‐3.00, P (trend) = .03). CONCLUSION: Our results support a role of inherited factors in the outcome of indolent lymphoma, including chronic lymphocytic leukemia. John Wiley and Sons Inc. 2020-09-29 2020-12 /pmc/articles/PMC7702025/ /pubmed/32871627 http://dx.doi.org/10.1111/ejh.13510 Text en © 2020 The Authors. European Journal of Haematology published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Baecklund, Fredrik
Ekberg, Sara
Rosenquist, Richard
Askling, Johan
Eloranta, Sandra
Smedby, Karin E.
Concordance in survival among first‐degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia
title Concordance in survival among first‐degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia
title_full Concordance in survival among first‐degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia
title_fullStr Concordance in survival among first‐degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia
title_full_unstemmed Concordance in survival among first‐degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia
title_short Concordance in survival among first‐degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia
title_sort concordance in survival among first‐degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702025/
https://www.ncbi.nlm.nih.gov/pubmed/32871627
http://dx.doi.org/10.1111/ejh.13510
work_keys_str_mv AT baecklundfredrik concordanceinsurvivalamongfirstdegreerelativesdiagnosedwithindolentlymphoidmalignanciesincludingchroniclymphocyticleukemia
AT ekbergsara concordanceinsurvivalamongfirstdegreerelativesdiagnosedwithindolentlymphoidmalignanciesincludingchroniclymphocyticleukemia
AT rosenquistrichard concordanceinsurvivalamongfirstdegreerelativesdiagnosedwithindolentlymphoidmalignanciesincludingchroniclymphocyticleukemia
AT asklingjohan concordanceinsurvivalamongfirstdegreerelativesdiagnosedwithindolentlymphoidmalignanciesincludingchroniclymphocyticleukemia
AT elorantasandra concordanceinsurvivalamongfirstdegreerelativesdiagnosedwithindolentlymphoidmalignanciesincludingchroniclymphocyticleukemia
AT smedbykarine concordanceinsurvivalamongfirstdegreerelativesdiagnosedwithindolentlymphoidmalignanciesincludingchroniclymphocyticleukemia